Editas Medicine (EDIT) Preferred Dividend Payments (2015 - 2016)
Editas Medicine (EDIT) reported Preferred Dividend Payments of $47000.0 for Q1 2016, down 50.53% year-over-year from $95000.0 in Q2 2015, and down 52.53% quarter-over-quarter from $99000.0 in Q4 2015.
Editas Medicine (EDIT) Preferred Dividend Payments (2015 - 2016) Analysis & Trends
Editas Medicine (EDIT) has 2 years of Preferred Dividend Payments data on file, last reported at $47000.0 in Q1 2016.
- Preferred Dividend Payments for Q1 2016 came in at $47000.0, down 50.53% year-over-year; the trailing twelve-month figure through Dec 2016 was $47000.0 (down 88.07% YoY), and the FY2016 annual result was $47000.0, down 88.07% from the prior year.
- Preferred Dividend Payments declined to $47000.0 in Q1 2016 per EDIT's latest filing, from $99000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $104000.0 in Q3 2015 and troughed at $47000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 47,000.00 |
| Dec 31, 2015 | 99,000.00 |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | 96,000.00 |
| Mar 31, 2015 | 95,000.00 |